Primary Treatment of Light Chain Amyloidosis with Bortezomib, Lenalidomide, and Dexamethasone (VRD): Effective Regimen Inducing Response w/in 3 mths, Toxicity Manageable
Comments 0
Login to view comments.
Click here to Login
